Prospect of Using Cell Product for the Therapy of Skin Defects in Diabetes Mellitus
- Authors: Lykov A.P.1,2, Bondarenko N.A.1,2, Poveshchenko O.V.1,2, Miller T.V.1, Poveshchenko A.F.1,2, Surovtseva M.A.1,2, Bgatova N.P.1, Konenkov V.I.1
-
Affiliations:
- Research Institute of Clinical and Experimental Lymphology
- E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
- Issue: Vol 164, No 2 (2017)
- Pages: 266-268
- Section: Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)
- URL: https://journals.rcsi.science/0007-4888/article/view/239545
- DOI: https://doi.org/10.1007/s10517-017-3970-0
- ID: 239545
Cite item
Abstract
The effectiveness of autologous cell product in the therapy of skin burn wounds was studied in C57B1/6 male mice against the background of streptozotocin-induced diabetes mellitus. In animals with and without modeled diabetes mellitus, significant decrease in skin defect area was observed after single administration of the cell product (bone marrow multipotent mesenchymal stromal cells, fibroblasts or media conditioned by these cells).
About the authors
A. P. Lykov
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Author for correspondence.
Email: aplykov2@mail.ru
Russian Federation, Novosibirsk; Novosibirsk
N. A. Bondarenko
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Russian Federation, Novosibirsk; Novosibirsk
O. V. Poveshchenko
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Russian Federation, Novosibirsk; Novosibirsk
T. V. Miller
Research Institute of Clinical and Experimental Lymphology
Email: aplykov2@mail.ru
Russian Federation, Novosibirsk
A. F. Poveshchenko
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Russian Federation, Novosibirsk; Novosibirsk
M. A. Surovtseva
Research Institute of Clinical and Experimental Lymphology; E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation
Email: aplykov2@mail.ru
Russian Federation, Novosibirsk; Novosibirsk
N. P. Bgatova
Research Institute of Clinical and Experimental Lymphology
Email: aplykov2@mail.ru
Russian Federation, Novosibirsk
V. I. Konenkov
Research Institute of Clinical and Experimental Lymphology
Email: aplykov2@mail.ru
Russian Federation, Novosibirsk